Immuno-Biological Laboratories Co.,Ltd.
TSE Growth
¥1,109.00
-3.06%
Delayed · cached 15 min
Frequently asked questions
What sector does Immuno-Biological Laboratories Co.,Ltd. belong to?
Immuno-Biological Laboratories Co.,Ltd. operates in the Pharmaceuticals sector, specifically the Pharmaceutical industry, and is listed on the US markets.
What is the current share price of 4570?
As of the latest available quote, 4570 traded at ¥1,109.00. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of 4570?
Immuno-Biological Laboratories Co.,Ltd. has a price-to-earnings (P/E) ratio of about 31.35. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of 4570?
The market capitalisation of Immuno-Biological Laboratories Co.,Ltd. is approximately ¥10.33B.
Is Immuno-Biological Laboratories Co.,Ltd. profitable?
For its latest reported financial year, Immuno-Biological Laboratories Co.,Ltd. recorded a net profit margin of about 32.74%.
Does 4570 pay a dividend?
Immuno-Biological Laboratories Co.,Ltd. currently has a dividend yield of about 0.52%.
What is the return on equity (ROE) of 4570?
Immuno-Biological Laboratories Co.,Ltd. has a return on equity (ROE) of about 19.60%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of 4570?
Over the past 52 weeks, 4570 has traded between a low of ¥464.00 and a high of ¥3,820.00.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.